FindTrial
Sign In

Management of kidney stones by giving decoction orally.

THE EFFICACY OF SHIGRU MULA KWATH IN THE MANAGEMENT OF MOOTRASHMARI WITH SPECIAL REFERENCE TO UROLITHIASIS - A RANDOMIZED CONTROLLED TRIAL.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040023
Enrollment
60
Registered
2022-02-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N202- Calculus of kidney with calculus of ureter

Interventions

None listed

Sponsors

Mali Shubham Sunil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling the diagnostic criteria which are based on signs and symptoms of Urolithiasis will be selected for study. Patients with size of calculus less than Patients having calculus at Kidney, Ureter, Bladder. Patients willing to participate in clinical trial with written consent.

Exclusion criteria

Exclusion criteria: Pregnancy / Lactation Patients not willing to participate in trial. Patients suffering from associated Urolithiasis with following disease will be excluded. Immunocompromised patient. Diabetic patients. Renal failure, congenital disorders like ectopic kidney, horse shoe kidney, stricture at Uretero Vesical & Uretero Pelvic junction, neoplasm. Patients having severe hydronephrosis.

Design outcomes

Primary

MeasureTime frame
Decrease in size of urinary calculi with treatment.Timepoint: Up to 30 days.—

Secondary

MeasureTime frame
Signs and symptoms of Urolithiasis will improve with treatment.Timepoint: Up to 30 days.—

Countries

India

Contacts

Public ContactDr Chandrakant Dhanokar

R T Ayurved Mahavidyalaya, Akola

jagdishdhanokar2010@rediffmail.com9975053354

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026